Search Results
Oct 13, 2025, 09:00 ET Experity Takes a Significant Step Toward the Touchless EMR with AI Scribe
set a higher standard of excellence. "AI Scribe is revolutionizing how providers engage with patients," said Andrea Giamalva, MD, chief medical officer at Experity. "Through metrics like talk-to-listen ratios and patient sentiment analysis, we can turn conversational data into actionable
More news about: Experity
Oct 13, 2025, 09:00 ET NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain
"The enrollment of the first patient in the RESORB trial marks an important milestone in our U.S. regulatory strategy," said Ziv J. Haskal, MD, Professor at the University of Virginia and CMO(Chief Medical Officer) of NEXTBIOMEDICAL. "With CE-MDD approval in Europe, thousands of successful procedures
More news about: NEXTBIOMEDICAL CO., LTD.
Oct 13, 2025, 08:00 ET Vasa Therapeutics Receives FDA IND Clearance to Advance Novel Small Molecule VS-041 for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)
milestone for Vasa, underscores the strength of our science and development strategy, and demonstrates exceptional execution," said Artur Plonowski, MD, Chief Executive Officer of Vasa Therapeutics. "This next study will evaluate potential important effects of VS-041 on clinical and prognostic biomarkers
More news about: Vasa Therapeutics
Oct 13, 2025, 08:00 ET Mount St. Mary's University Launches New Instructional Design and Technology Degree Programs
education, technology, and innovation. EMMITSBURG, Md., Oct. 13, 2025 /PRNewswire/ -- In Spring 2026, Mount St. Mary's University's Division of Continuing Studies (DCS)
More news about: Mount St. Mary's University
Oct 13, 2025, 07:57 ET Orbis International's Flying Eye Hospital Returns to Ghana to Train Local Eye Care Teams
technologies and training support to help equip Ghana's eye care professionals with the tools they need to succeed." FedEx donated the MD-10 aircraft that became the current Flying Eye Hospital and also provides Orbis with ongoing financial support, in-kind shipping, and global aircraft
More news about: Orbis International
Oct 13, 2025, 07:30 ET Federal Realty Acquires Annapolis Town Center, Advancing Disciplined Acquisition Strategy
underscores Federal's strong execution NORTH BETHESDA, Md., Oct. 13, 2025 /PRNewswire/ --
More news about: Federal Realty Investment Trust
Oct 13, 2025, 07:00 ET Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting
Samuel Barone, MD, Chief Medical Officer, Nanoscope Therapeutics Title: "152-Week REMAIN Data from Extended Analysis
More news about: Nanoscope Therapeutics
Oct 13, 2025, 07:00 ET Hughes and Gogo Celebrate Key FDX and HDX Aviation ESA Milestones
the on-time arrival of HDX and FDX ESAs GERMANTOWN, Md., Oct. 13, 2025 /PRNewswire/ --
More news about: Hughes Network Systems, LLC
Oct 13, 2025, 07:00 ET Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis
long-term follow-up GERMANTOWN, Md., Oct. 13, 2025 /PRNewswire/ --
More news about: Precigen, Inc.
Oct 12, 2025, 18:27 ET Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025
radiotherapy. "Treatment options are limited for patients with NSCLC with EGFR mutations and active brain metastases," said Helena A. Yu, MD, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer. "We are pleased to see that in approximately one-third of patients exposed to zipalertinib,
More news about: Taiho Oncology
Oct 11, 2025, 14:11 ET Taraji P. Henson's Boris Lawrence Henson Foundation (BLHF) Announce 5th Annual Can We Talk? Arts & Wellness Summit and "i AM The Table" Benefit Brunch
Three Days of Culture, Healing, and Community, October 10-12, 2025 at National Harbor, MD. NATIONAL HARBOR, Md., Oct. 11, 2025 /PRNewswire/ -- The Boris Lawrence Henson
More news about: Boris Lawrence Henson Foundation
Oct 11, 2025, 09:30 ET LAS PERSONAS QUE RECIBEN MENOS SEDACIÓN CUANDO DEPENDEN DE UN RESPIRADOR TIENEN MÁS PROBABILIDADES DE VOLVER A LLEVAR UNA VIDA AUTÓNOMA TRAS LA HOSPITALIZACIÓN
puede privar del sueño reparador y saludable que más necesita el paciente extenuado en su enfermedad", afirma el autor del artículo, Matthias Eikermann, MD, Profesor y Chair Francis F. Foldes del Departamento de Anestesiología de Montefiore Einstein. "Nuestros datos muestran que esta falta de sueño de calidad
More news about: Montefiore Health System
Oct 10, 2025, 19:09 ET MindClay Brings "Interactive Museum" Wellness Lounge to Behavioral Health Tech 2025 in San Diego
Chris DeCou, PhD, Director of Amazon Health Benefits, Amazon Sandy Balwan, MD, Chief Medical Officer, Northwell Tuoyo Louis, Co-Founder & Managing Partner, Seae Ventures
More news about: MindClay
Oct 10, 2025, 17:10 ET Hydro One to Release Third Quarter 2025 Results on November 13, 2025 Before Markets Open
morning of November 13, 2025, before North American financial markets open. A summary of the results will be distributed by newswire and the complete MD&A and financial statements will be posted at
More news about: Hydro One Limited
Oct 10, 2025, 15:31 ET Alamar Biosciences Luncurkan NULISAqpcr™ BD-pTau217 Assay: Terobosan Deteksi Biomarker Non Invasif Khusus Otak Untuk Penelitian Penyakit Alzheimer
dengan presisi lebih tinggi." "Kinerja Alamar atas pTau217 assay plasma khusus otak sungguh luar biasa," kata Jonathan Schott, MD, PhD, Profesor Neurologi di University College London. "Untuk mendeteksi patologi Alzheimer dengan gejala kognitif, hasil awal kami menunjukkan bahwa
More news about: Alamar Biosciences, Inc.
Oct 10, 2025, 14:11 ET Společnost Alamar Biosciences uvádí na trh test NULISAqpcr™ BD-pTau217: průlom v neinvazivní detekci biomarkerů specifických pro mozek v rámci výzkumu Alzheimerovy choroby
dříve a s vyšší přesností." „Výkon testů pTau217 společnosti Alamar specifických pro mozek je vynikající," uvedl Jonathan Schott, MD, PhD, profesor neurologie na University College London. „Pokud jde o detekci Alzheimerovy patologie s kognitivními symptomy, naše předběžné výsledky naznačují,
More news about: Alamar Biosciences, Inc.
Oct 10, 2025, 14:06 ET Alamar Biosciences uvádza na trh test NULISAqpcr™ BD-pTau217: Prevratnú novinku v neinvazívnej detekcii biomarkerov špecifických pre mozog na výskum Alzheimerovej choroby
presnosťou." „Výkonnosť testov pTau217 pre plazmu špecifickú pre mozog od spoločnosti Alamar je vynikajúca," povedal Jonathan Schott, MD, PhD, profesor neurológie na University College London. „Naše rané výsledky naznačujú, že pri detekcii patológie Alzheimerovej choroby s kognitívnymi
More news about: Alamar Biosciences, Inc.
Oct 10, 2025, 13:46 ET Alamar Biosciences bringt NULISAqpcr™ BD-pTau217 Assay auf den Markt: Durchbruch beim nicht-invasiven, hirnspezifischen Biomarker-Nachweis für die Alzheimer-Forschung
Präzision erkennen." „Die Leistung der hirnspezifischen pTau217-Plasmatests von Alamar ist ausgezeichnet", sagt Jonathan Schott, MD, PhD, Professor für Neurologie am University College London. „Für den Nachweis von Alzheimer-Pathologie mit kognitiven Symptomen deuten unsere ersten
More news about: Alamar Biosciences, Inc.
Oct 10, 2025, 12:35 ET Alamar Biosciences lance le test NULISAqpcr™ BD-pTau217 : une avancée dans la détection non invasive de biomarqueurs spécifiques au cerveau pour la recherche sur la maladie d'Alzheimer
« La performance des dosages de pTau217 dans le plasma spécifique au cerveau d'Alamar est excellente », déclare Jonathan Schott, MD, PhD, professeur de neurologie à l'University College London. « Pour la détection de la pathologie d'Alzheimer avec des symptômes cognitifs, nos premiers
More news about: Alamar Biosciences, Inc.
Oct 10, 2025, 10:00 ET Mount St. Mary's University Secures $115,182 Grant from the Rural Maryland Council
learning spaces in the Richard J. Bolte Sr. School of Business EMMITSBURG, Md., Oct. 10, 2025 /PRNewswire/ -- Mount St. Mary's University received a $115,182 grant from the Rural Maryland
More news about: Mount St. Mary's University
Oct 10, 2025, 10:00 ET Nordstrom Rack to Open New Location in Rehoboth Beach, DE
a developer and owner of retail and mixed-use properties throughout the Mid-Atlantic and New England. Based in Baltimore with an office in Bethesda, MD, the company pursues new investment opportunities – either through Greenfield development, or by purchasing under-performing assets in need of redevelopment.
More news about: Nordstrom, Inc.
Oct 10, 2025, 09:42 ET The ACMG Establishes Newborn Screening Coalition to Continue National Leadership in Advancing Evidence-Based Newborn Screening
(HRSA), ACMG President Mira B. Irons, MD, FACMG convened a Taskforce of ACMG members to develop a process for maintaining national oversight and evaluation of potential additions to the Recommended Uniform Screening Panel (RUSP). The Taskforce, chaired by Cynthia Powell, MD, FACMG, convened a roundtable with
More news about: American College of Medical Genetics and Genomics
Oct 10, 2025, 09:01 ET NEUROMARK® Treatment for Chronic Rhinitis Demonstrates Durable 2-Year Clinical Benefits
suffering from chronic rhinitis, addressing not only nasal symptoms but also postnasal drip, cough, and ear-related complaints," said Dr. David Yen, MD, lead author of the publication. "The consistency of improvements through two years underscores the potential for NEUROMARK to be a transformative therapy
More news about: Neurent Medical
Oct 10, 2025, 09:00 ET Foundation Fighting Blindness Marks World Mental Health Day with Upcoming Webinar for Eye Care Professionals: Seeing Beyond Vision Loss - A Focus on Mental Health Resources for Patients with Retinal Disease
patient advocate Jessie Wolinsky, retina specialist Sandeep Grover, MD, and clinical psychologist Ann Wagner, PhD, LP, ABPP. COLUMBIA, Md., Oct. 10, 2025 /PRNewswire/ --
More news about: Foundation Fighting Blindness
Oct 10, 2025, 08:30 ET Marriott International Announces Release Date For Third Quarter 2025 Earnings
BETHESDA, Md., Oct. 10, 2025 /PRNewswire/ -- Marriott International, Inc. (Nasdaq: MAR) will report third quarter 2025 earnings results on Tuesday, November 4, 2025, at approximately 7:00
More news about: Marriott International, Inc.